SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes.

Herat, Lakshini Yasaswi; Matthews, Jennifer Rose; Hibbs, Moira; Rakoczy, Elizabeth Piroska; Schlaich, Markus Peter; Matthews, Vance Bruce

Herat, Lakshini Yasaswi; Matthews, Jennifer Rose; Hibbs, Moira; Rakoczy, Elizabeth Piroska; Schlaich, Markus Peter; Matthews, Vance Bruce.

Afiliación

Herat LY; Dobney Hypertension Centre, School of Biomedical Sciences - Royal Perth Hospital Unit / Royal Perth Hospital Medical Research Foundation, University of Western Australia, Crawley, WA 6009, Australia.
Matthews JR; Dobney Hypertension Centre, School of Biomedical Sciences - Royal Perth Hospital Unit / Royal Perth Hospital Medical Research Foundation, University of Western Australia, Crawley, WA 6009, Australia.
Hibbs M; Research Centre, Royal Perth Hospital, Perth, WA 6000, Australia.
Rakoczy EP; Department of Molecular Ophthalmology, University of Western Australia, Crawley, WA 6009, Australia.
Schlaich MP; Dobney Hypertension Centre, Medical School - Royal Perth Hospital Unit / Royal Perth Hospital Medical Research Foundation, University of Western Australia, Crawley, WA 6009, Australia.
Matthews VB; Department of Cardiology and Department of Nephrology, Royal Perth Hospital, Perth, WA 6000, Australia.

iScience ; 26(8): 107260, 2023 Aug 18.

Article en En | MEDLINE | ID: mdl-37520739

Palabras clave

Cell biology; Human metabolism

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: IScience Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google